From MSM model: Assessing two-way interactions between gender and smoking history for post-progression survival (N = 104/123).

PurposeTreatment and clinical-outcomes were described in a sub-cohort of non-small-cell lung cancer (NSCLC) patients with disease-progression (PD) after epidermal growth factor...

Baseline clinicopathological features of EGFRmut+ NSCLC patients (N = 104/123; N = 94/104).